AstraZeneca cancer drug fails in mesothelioma trial

LONDON (Reuters) - AstraZeneca said a closely watched experimental cancer drug failed in a clinical trial when used on its own to treat mesothelioma, a rare lung and abdominal cancer, but it remained confident the drug had a role to play in combination treatments.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro